Impact of estradiol valerate/dienogest on work productivity and activities of daily living in women with heavy menstrual bleeding

Journal of Women's Health

Volumn 22, Issue 4, 2013, Pages 378-383

  Wasiak, Radoslaw ^a   Filonenko, Anna ^b   Vanness, David J ^c   Law, Amy ^d   Jeddi, Mark ^e   Wittrup Jensen, Kim U ^b   Stull, Donald E ^a   Siak, Steven ^a   Jensen, Jeffrey T ^f  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b BAYER PHARMA AG   (Germany)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d BAYER CORPORATION   (United States)

^e Bayer Inc   (Canada)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIENOGEST PLUS ESTRADIOL VALERATE; PLACEBO;

ADULT; ARTICLE; CANADA; CONTROLLED STUDY; DAILY LIFE ACTIVITY; HEAVY MENSTRUAL BLEEDING; HUMAN; LIKERT SCALE; MENSTRUATION DISORDER; MODIFIED WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT QUESTIONNAIRE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PRODUCTIVITY; RANDOMIZED CONTROLLED TRIAL; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; CARDIOVASCULAR DISEASES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MASS SCREENING; NORTH CAROLINA; POVERTY AREAS; PREGNANCY; REPRODUCTIVE HEALTH; RISK FACTORS;

EID: 84876245092     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2012.3633     Document Type: Article

References (41)

1. Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss\-a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1966;45:320-351.
2. National Collaborating Centre for Women's and Children's Health. Heavy menstrual bleeding. Clinical guideline. Na-tional Institute for Health and Clinical Excellence. London: RCOG Press, 2007.
3. Cote I, Jacobs P, Cumming D. Work loss associated with increased menstrual loss in the United States. Obstet Gyne-col 2002;100:683-687.
4. Frick KD, Clark MA, Steinwachs DM, et al. Financial and quality-of-life burden of dysfunctional uterine bleeding among women agreeing to obtain surgical treatment. Wo-mens Health Issues 2009;19:70-78.
5. Abbott J, Hawe J, Hunter D, Holmes M, Finn P, Garry R. Laparoscopic excision of endometriosis: a randomized, pla-cebo-controlled trial. Fertil Steril 2004;82:878-884.
6. Bushnell DM, Martin ML, Ricci JF, Bracco A. Performance of the EQ-5D in patients with irritable bowel syndrome. Value Health 2006;9:90-97
7. Matza LS, Boye KS, Yurgin N. Validation of two generic patient-reported outcome measures in patients with type 2 diabetes. Health Qual Life Outcomes 2007;5:47.
8. Philipp CS, Faiz A, Dowling N, et al. Age and the prevalence of bleeding disorders in women with menorrhagia. Obstet Gynecol 2005;105:61-66.
9. Sculpher M. A cost-utility analysis of abdominal hysterec-tomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. Int J Technol Assess Health Care 1998;14:302-319.
10. Shapley M, Jordan K, Croft PR Why women consult with increased vaginal bleeding: a case-control study. Br J Gen Pract 2002;52:108-113.
11. Bishaw A, Semega J. Income, earnings, and poverty data from the 2007 American Community Survey. Washington, DC: U.S. Census Bureau, 2008.
12. Liu Z, Doan QV, Blumenthal P, Dubois RW. A systematic review evaluating health-related quality of life, work im-pairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health 2007;10:183-194.
13. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 81, May 2007. Obstet Gynecol 2007;109:1233-1248.
14. Amann M, Anguino H, Bauman RA, et al. Chronic abnormal uterine bleeding in nongravid women. Pasadena, CA: Kaiser Permanente Southern California, 2006.
15. Vilos GA, Lefebvre G, Graves GR. SOGC Clinical Practice Guidelines: guidelines for the management of abnormal uterine bleeding. J Obstet Gynaecol Can 2001;23:704-709.
16. Clarke J. Treatment of heavy menstrual bleeding. BMJ 2010; 341:c3771.
17. Brown JS, Sawaya G, Thom DH, Grady D. Hysterectomy and urinary incontinence: a systematic review. Lancet 2000; 356:535-539.
18. Overton C, Hargreaves J, Maresh M. A national survey of the complications of endometrial destruction for menstrual disorders: the MISTLETOE study. Minimally Invasive Surgical Techniques\-Laser, EndoThermal or Endorescetion. Br J Obstet Gynaecol 1997;104:1351-1359.
19. McCausland AM, McCausland VM. Long-term complica-tions of endometrial ablation: cause, diagnosis, treatment, and prevention. J Minim Invasive Gynecol 2007;14:399-406.
20. Kaunitz AM, Meredith S, Inki P, Kubba A, Sanchez-Ramos L. Levonorgestrel-releasing intrauterine system and endo-metrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis. Obstet Gynecol 2009;113:1104-1116.
21. Jensen JT, Parke S, Mellinger U, Machlitt A, Fraser IS. Ef-fective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial. Obstet Gynecology 2011;117:777-787.
22. Fraser IS, Romer T, Parke S, et al. Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial. Hum Reprod 2011; 26:2698-2708.
23. Wasiak R, Filonenko A, Vanness DJ, et al. Impact of estra-diol-valerate dienogest on work productivity and activities of daily living in European and Australian women with heavy menstrual bleeding. Int J Women's Health 2012;4: 271-278.
24. Reilly MC, Zbrozek AS, Dukes EM. The validity and re-producibility of a work productivity and activity impair-ment instrument. Pharmacoeconomics 1993;4:353-365.
25. Work Productivity and Activity Impairment Questionnaire Scoring. 2002. Available at: http://www.reillyassociates .net/WPAI-Scoring.html (accessed March 3, 2011).
26. WinBugs. Available at: http://www.mrc-bsu.cam.ac.uk/ bugs/winbugs/ contents.shtml (accessed March 3, 2011).
27. Gelman A, Hill J. Data analysis using regression and mul-tilevel/ hierarchical models Cambridge UK: Cambridge University Press, 2006.
28. Manca A, Sculpher MJ, Goeree R. The analysis of multina-tional cost-effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments. Pharmacoeconomics 2010;28:1079-1096.
29. Spiegelhalter DJ, Best NG, Carlin BP, Van der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc Ser B 2002;64:583-616.
30. International Labour Organization. LABORSTA\-database of labour statistics. Available at: http://laborsta.ilo.org/ (accessed November 20, 2009).
31. El Senoun GS, Mousa HA, Mahmood TA. Medium-term follow-up of women with menorrhagia treated by rollerball endometrial ablation. Acta Obstet Gynecol Scand 2000;79: 879-883.
32. Goldrath MH. Evaluation of HydroThermAblator and roll-erball endometrial ablation for menorrhagia 3 years after treatment. J Am Assoc Gynecol Laparosc 2003;10:505-511.
33. Loffer FD. Three-year comparison of thermal balloon and rollerball ablation in treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2001;8:48-54.
34. Mousa HA, Abou El Senoun GM, Mahmood TA. Medium-term clinical outcome of women with menorrhagia treated by rollerball endometrial ablation versus abdominal hys-terectomy with conservation of at least one ovary. Acta Obstet Gynecol Scand 2001;80:442-446.
35. Sambrook AM, Bain C, Parkin DE, Cooper KG. A rando-mised comparison of microwave endometrial ablation with transcervical resection of the endometrium: follow up at a minimum of 10 years. BJOG 2009;116:1033-1037
36. Sculpher MJ, Dwyer N, Byford S, Stirrat GM. Randomised trial comparing hysterectomy and transcervical endome-trial resection: effect on health related quality of life and costs two years after surgery. Br J Obstet Gynaecol 1996; 103:142-149.
37. Wade SW, Magee G, Metz L, Broder MS. Cost-effectiveness of treatments for dysfunctional uterine bleeding. J Reprod Med 2006;51:553-562.
38. Abel U, Koch A. The role of randomization in clinical studies: myths and beliefs. J Clin Epidemiol 1999;52:487-497.
39. Fleurence RL, Naci H, Jansen JP. The critical role of obser-vational evidence in comparative effectiveness research. Health Aff (Millwood) 2010;29:1826-1833.
40. Prasad M, Wahlqvist P, Shikiar R, Shih YC. A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective. Pharma-coeconomics 2004;22:225-244.
41. Jenkinson C, Peto V, Coulter A. Making sense of ambiguity: evaluation in internal reliability and face validity of the SF 36 questionnaire in women presenting with menorrhagia. Qual Health Care 1996;5:9-12.